Ehrlich et al., 2021 - Google Patents
Oncolytic virotherapy: the cancer cell sideEhrlich et al., 2021
View HTML- Document ID
- 15289343073792682262
- Author
- Ehrlich M
- Bacharach E
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary Oncolytic viruses (OVs) are a promising immunotherapy that specifically target and kill cancer cells and stimulate anti-tumor immunity. While different OVs are endowed with distinct features, which enhance their specificity towards tumor cells; attributes …
- 201000011510 cancer 0 title abstract description 119
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moon et al. | MAPK/ERK signaling pathway in hepatocellular carcinoma | |
| Vrána et al. | From tumor immunology to immunotherapy in gastric and esophageal cancer | |
| Santaniello et al. | Tumour microenvironment and immune evasion in EGFR addicted NSCLC: hurdles and possibilities | |
| Bose | cGAS/STING pathway in cancer: Jekyll and Hyde story of cancer immune response | |
| Moens et al. | The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer | |
| Balog et al. | Single cell mass cytometry revealed the immunomodulatory effect of cisplatin via downregulation of splenic CD44+, IL-17A+ MDSCs and promotion of circulating IFN-γ+ myeloid cells in the 4T1 metastatic breast cancer model | |
| Ibba et al. | Disruption by SaCas9 endonuclease of HERV-K Env, a retroviral gene with oncogenic and neuropathogenic potential, inhibits molecules involved in cancer and amyotrophic lateral sclerosis | |
| Ehrlich et al. | Oncolytic virotherapy: the cancer cell side | |
| Hofman et al. | The multifaceted role of macrophages in oncolytic virotherapy | |
| Bourhill et al. | Going (reo) viral: Factors promoting successful reoviral oncolytic infection | |
| Florent et al. | BRAF V600-mutated metastatic melanoma and targeted therapy resistance: an update of the current knowledge | |
| Ammour et al. | The susceptibility of human melanoma cells to infection with the Leningrad-16 vaccine strain of measles virus | |
| Muthukutty et al. | Oncolytic virus engineering and utilizations: cancer immunotherapy perspective | |
| Simon et al. | Serotype-specific killing of large cell carcinoma cells by reovirus | |
| Federico | How do anti-SARS-CoV-2 mRNA vaccines protect from severe disease? | |
| Kordbacheh et al. | Molecular pathways and druggable targets in head and neck squamous cell carcinoma | |
| Tsui et al. | Mucosa-associated lymphoid tissue 1 is an oncogene inducing cell proliferation, invasion, and tumor growth via the upregulation of NF-κB activity in human prostate carcinoma cells | |
| Peixoto et al. | The Chromatin Remodeler HELLS: a new regulator in DNA repair, genome maintenance, and cancer | |
| Lee et al. | Therapeutic efficacy of GC1118, a novel anti-EGFR antibody, against glioblastoma with high EGFR amplification in patient-derived xenografts | |
| Zhang et al. | Immune checkpoint inhibitors in HBV-caused hepatocellular carcinoma therapy | |
| Liu et al. | The cross talk between cellular senescence and melanoma: From molecular pathogenesis to target therapies | |
| Cao et al. | Terpinen-4-ol induces Ferroptosis of glioma cells via downregulating JUN proto-oncogene | |
| Pandey et al. | Deciphering the immunomodulatory role of cyclin-dependent kinase 4/6 inhibitors in the tumor microenvironment | |
| Shi et al. | TNFR1 and TNFR2, which link NF-κB activation, drive lung cancer progression, cell dedifferentiation, and metastasis | |
| Berchtold et al. | Assessing and overcoming resistance phenomena against a genetically modified vaccinia virus in selected cancer cell lines |